BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 2974988)

  • 1. [Toxicity in the current treatment of pulmonary tuberculosis in children].
    Altet Gómez MN; Alcáide Megías J; Boque Genovard MA
    An Esp Pediatr; 1984 Jan; 20(1):18-27. PubMed ID: 6230974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difficult clinical management of anti-tuberculosis DRESS syndrome.
    Palmero D; Castagnino J; Musella RM; Mosca C; González Montaner P; de Casado GC
    Int J Tuberc Lung Dis; 2013 Jan; 17(1):76-8. PubMed ID: 23114284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frequency, pattern, and diagnosis of adverse reactions in patients with pulmonary tuberculosis during chemotherapy with leading drugs].
    Mishin VIu; Vasil'eva IA; Makieva VG; Kuz'mina NV; Prikazchikova AV; Khoroshutina VV
    Probl Tuberk Bolezn Legk; 2003; (7):24-9. PubMed ID: 12939872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of a mathematic method of prognosis in adverse reactions to chemotherapy of tuberculosis].
    Kazakov KS; Kozarev MI
    Probl Tuberk; 1987; (2):43-5. PubMed ID: 3575279
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatic jaundice in patients with pulmonary tuberculosis treated with various combinations of antitubercular drugs].
    Kubiak Z
    Gruzlica; 1968 Oct; 36(11):1133-5. PubMed ID: 5710701
    [No Abstract]   [Full Text] [Related]  

  • 6. [Incidence and nature of adverse reactions to antitubercular drugs in children with primary intrathoracic tuberculosis].
    Kurmanova NK
    Probl Tuberk; 1988; (6):33-6. PubMed ID: 2974988
    [No Abstract]   [Full Text] [Related]  

  • 7. [Side-effects of antitubercular chemoantibiotic therapy].
    Legramante A; Pelagalli LA; Santilli E
    Clin Ter; 1977 May; 81(4):363-79. PubMed ID: 195766
    [No Abstract]   [Full Text] [Related]  

  • 8. SIDE EFFECTS OF TUBERCULOSIS TREATMENT WITH FIXED-DOSE COMBINATIONS.
    Zhang HQ; Xi XE; Wang YL; Han W; Zhang CX; Jiao JH
    J Biol Regul Homeost Agents; 2015; 29(2):379-88. PubMed ID: 26122226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacology, toxicology and clinical use of pyrazinamide (author's transl)].
    Zierski M
    Prax Klin Pneumol; 1981 Dec; 35(12):1075-1105. PubMed ID: 6808484
    [No Abstract]   [Full Text] [Related]  

  • 10. Toxicity of first-line drugs for treatment of tuberculosis in children: review.
    Frydenberg AR; Graham SM
    Trop Med Int Health; 2009 Nov; 14(11):1329-37. PubMed ID: 19735381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis in children with tuberculosis: a case report and review of the literature.
    Sanchez-Codez M; Hunt WG; Watson J; Mejias A
    BMC Pulm Med; 2020 Jun; 20(1):173. PubMed ID: 32546255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rational use of hepato-protectants in the prophylaxis and treatment of anti-tuberculosis drug-induced hepatotoxicity].
    Gu J; Xiao HP
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):767-9. PubMed ID: 24433806
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.